Keyphrases
Percutaneous Coronary Intervention
100%
Clinical Outcomes
29%
Stent
28%
Drug-eluting Stent
26%
Confidence Interval
24%
Acute Myocardial Infarction
23%
Myocardial Infarction
23%
ST-elevation Myocardial Infarction (STEMI)
23%
Revascularization
22%
Acute Coronary Syndrome
21%
Transcatheter Aortic Valve Replacement
21%
Stent Thrombosis
18%
Bleeding
18%
Major Bleeding
17%
Dual Antiplatelet Therapy
16%
Intravascular Ultrasound
15%
Bivalirudin
15%
Randomized Trial
15%
Hazard Ratio
15%
Adverse Cardiac Events
14%
In-stent Restenosis
13%
Primary Percutaneous Coronary Intervention
13%
Aspirin
12%
Meta-analysis
12%
Target Lesion Revascularization
11%
All-cause Mortality
11%
Ticagrelor
10%
Type 1 Diabetes Mellitus (T1DM)
10%
Chronic Kidney Disease
10%
Transcatheter Aortic Valve Implantation
10%
Stent Implantation
10%
Coronary Artery Bypass Grafting
9%
High Risk
9%
Coronary Artery Disease
9%
Clinical High Risk
9%
Major Adverse Cardiovascular Events
8%
Heparin
8%
Glycoprotein IIb/IIIa Inhibitors
8%
Clopidogrel
8%
Bleeding Risk
8%
Antithrombotic Therapy
7%
Coronary Artery Bypass Graft Surgery
7%
Odds Ratio
7%
Target Vessel Revascularization
7%
Systematic Meta-analysis
7%
Chronic Total Occlusion
7%
Catheterization
7%
Urgent Intervention
7%
Sirolimus-eluting Stent
7%
Restenosis
7%
Medicine and Dentistry
Percutaneous Coronary Intervention
84%
Percutaneous Aortic Valve Replacement
28%
Drug-Eluting Stent
27%
Myocardial Infarction
26%
Revascularization
21%
Coronary Artery Disease
18%
Acute Coronary Syndrome
18%
Intravascular Ultrasound
18%
Antiplatelet
17%
Bleeding
15%
Acute Heart Infarction
14%
Stent Thrombosis
14%
Restenosis
13%
Diabetes Mellitus
13%
Hazard Ratio
12%
Major Bleeding
12%
Stenting
12%
Meta-Analysis
11%
ST Segment Elevation Myocardial Infarction
11%
Disease
11%
Target Lesion Revascularization
11%
Apoplexy
11%
In-Stent Restenosis
11%
Antithrombotic
10%
Cardiovascular Disease
10%
Coronary Artery Bypass Graft
9%
Cardiovascular System
9%
Chronic Kidney Disease
8%
Rapamycin
8%
Catheterization
8%
Bivalirudin
8%
Coronary Artery
7%
Major Adverse Cardiac Event
7%
Chronic Total Occlusion
7%
Heparin
7%
Angioplasty
7%
Odds Ratio
6%
Primary Percutaneous Coronary Intervention
6%
Pooled Analysis
6%
Randomized Controlled Trial
6%
Atrial Fibrillation
6%
Triage
6%
Adverse Event
6%
Anticoagulation
6%
Target Vessel Revascularization
6%
Acute Kidney Injury
5%
Stenosis
5%
Artery
5%
All Cause Mortality
5%
Prevalence
5%
Pharmacology, Toxicology and Pharmaceutical Science
Bleeding
30%
Heart Infarction
28%
Acute Heart Infarction
21%
Acute Coronary Syndrome
17%
ST Segment Elevation Myocardial Infarction
17%
Antiplatelet
16%
Stent Thrombosis
16%
Bivalirudin
16%
Heparin
13%
Ticagrelor
13%
Diabetes Mellitus
12%
Coronary Artery Disease
12%
Acetylsalicylic Acid
12%
Cardiovascular Disease
11%
Monotherapy
10%
Anticoagulant Agent
9%
Disease
9%
Randomized Controlled Trial
8%
Chronic Kidney Failure
7%
Major Adverse Cardiac Event
7%
Clopidogrel
7%
Fibrinogen Receptor
7%
All Cause Mortality
6%
Restenosis
5%
Atrial Fibrillation
5%
Acute Kidney Failure
5%
Biological Marker
5%
C Reactive Protein
5%